A pre-filing landscape checklist that has shaped how several university spinouts approached their first patents.
Novelty is necessary, not sufficient
Most invention disclosures that reach a technology transfer office get evaluated primarily on novelty — has this been done before, is it patentable subject matter, does it clear the basic bar for filing. That evaluation matters, but it answers a narrower question than the one a TTO actually needs answered, which is whether filing is worth the cost given what the patent would realistically protect and who would realistically want it.
A genuinely novel disclosure can still be a weak filing candidate if the novelty sits in a part of the invention that's easy to design around, or if the commercial path for the underlying research doesn't need composition-level patent protection to be viable. Conversely, an incremental improvement on existing technology can be a strong filing candidate if it closes a gap that's commercially significant, even though the underlying novelty is modest.
What the novelty check should actually confirm
Beyond the basic "has this been published before" question, a useful pre-filing novelty check should establish:
- Where the closest prior art sits relative to the disclosure, not just whether it exists — a disclosure that's clearly distinguishable from the nearest prior art supports a different filing strategy than one that's novel only on a narrow technical distinction.
- Whether the novel element is the commercially valuable part of the invention, or whether it's incidental to the parts of the work that actually matter for licensing or spinout formation.
- How crowded the surrounding technology space is, since a disclosure that's novel in a sparse landscape has more room for broad claims than one that's novel in a dense one.
The commercial assessment questions that matter
Once novelty is established, the questions that actually determine whether filing is worth the cost are different in kind:
- Who would license or need this, specifically — not "this technology has applications in X," but which category of organization would realistically pay for freedom to use it, and whether that category exists in meaningful numbers.
- What would a licensee actually be buying — composition protection, a method that's hard to detect if infringed, a research tool with a narrow but real market. The answer changes what claim scope is worth pursuing.
- Whether the invention is a platform or a point solution — platform technologies that support multiple downstream applications generally justify broader, more expensive prosecution than single-application inventions, because the licensing surface is larger.
- What the enforcement picture looks like — an invention that's easy to detect if used (a physical product, a testable formulation) supports a different filing strategy than one that's difficult to detect in practice (an internal process, a training method), where infringement may be nearly impossible to identify after the fact.
Why sequencing the two checks matters
Running the commercial assessment before or in parallel with the novelty check, rather than after it, changes what the novelty check is even looking for. If the commercial answer is that a broad platform claim is what would actually be licensable, the novelty search needs to test whether that broad scope is defensible — not just whether the disclosure as originally written is novel. Running novelty first and commercial assessment second often means the novelty work has to be redone once the actual claim scope worth pursuing becomes clear.
Key takeaway
A disclosure that clears novelty deserves a commercial answer before it gets a filing decision, and the two checks are more useful run together than run in sequence. The filings that hold up best are the ones where the claim scope being pursued was chosen because it matches what's actually licensable, not just because it's what the original disclosure happened to describe.